Troubleshooting Report - cIEF and materials for CZE
cIEF and materials for CZE
Workshop facilitators: Tim Blanc1, Cari Sänger-van de Griend2
Scribes: Jiann-Kae Luo3, Joel Welch4, Tara Enda5
Compilation: Jiann-Kae Luo
1. Eli Lilly and Company, Branchburg, NY, USA
2. Kantisto BV, Baarn, the Netherlands; Uppsala University, Div. of Pharmaceutical Analytical Chemistry, Uppsala, Sweden; ACROSS, University of Tasmania, Hobart, Australia
3. Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
4. Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
This publication reflects the views of the author and should not be construed to represent FDA's views or policies.
5. Eli Lilly and Company, Branchburg, NY, USA
Workshop facilitators: Tim Blanc1, Cari Sänger-van de Griend2
Scribes: Jiann-Kae Luo3, Joel Welch4, Tara Enda5
Compilation: Jiann-Kae Luo
1. Eli Lilly and Company, Branchburg, NY, USA
2. Kantisto BV, Baarn, the Netherlands; Uppsala University, Div. of Pharmaceutical Analytical Chemistry, Uppsala, Sweden; ACROSS, University of Tasmania, Hobart, Australia
3. Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
4. Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
This publication reflects the views of the author and should not be construed to represent FDA's views or policies.
5. Eli Lilly and Company, Branchburg, NY, USA